Diverse microglial responses after intrahippocampal administration of lipopolysaccharide
Inflammation has been argued to play a primary role in the pathogenesis of Alzheimer's disease by contributing to the development of neuropathology and clinical symptoms. However, the mechanisms underlying these effects remain obscure. Lipopolysaccharide (LPS) activates the innate immune respon...
Gespeichert in:
Veröffentlicht in: | Glia 2006-03, Vol.53 (4), p.382-391 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 391 |
---|---|
container_issue | 4 |
container_start_page | 382 |
container_title | Glia |
container_volume | 53 |
creator | Herber, Donna L. Maloney, Jessica L. Roth, Lisa M. Freeman, Melissa J. Morgan, Dave Gordon, Marcia N. |
description | Inflammation has been argued to play a primary role in the pathogenesis of Alzheimer's disease by contributing to the development of neuropathology and clinical symptoms. However, the mechanisms underlying these effects remain obscure. Lipopolysaccharide (LPS) activates the innate immune response and triggers gliosis when injected into the central nervous system. In the studies described in the present work, we evaluated the time course of microgliosis after a single intrahippocampal injection of LPS. Mice were injected bilaterally with 4 μg of LPS. Post‐injection survival times were 1, 6, and 24 h, as well as 3, 7, 14, and 28 days. Protein and RNA analyses were performed for inflammatory markers. Significant elevations of cluster differentiation marker CD45, glial fibrillary acidic protein (GFAP), scavenger receptor A (SRA), and Fcγ receptor mRNA were seen after 24 h. Immunohistochemistry revealed a complex pattern of protein expression by microglia, as well as changes in cell morphologies. RNA and protein for Fcγ receptor and SRA were transiently elevated, peaked at 3 days, and returned to basal levels after 1 week. In contrast, microglia remained significantly activated through the 28‐day time point, as determined by CD45 and complement receptor 3 levels. These findings indicate a multivariate response to LPS, and evaluation of microglial phenotypes may lead to a better understanding of neuroinflammatory diseases. © 2005 Wiley‐Liss, Inc. |
doi_str_mv | 10.1002/glia.20272 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70698465</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70698465</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3952-e875a1a65e125a33333da34922695054f62ffc574326793a9c31e750e51cc7c73</originalsourceid><addsrcrecordid>eNp9kE9vEzEQxS1ERUPgwgdAe4ED0rb-7_WxKhAqolYIaLlZgzNLDd71YidAvj0OCfTGXEYz-s0bvUfIE0ZPGKX89EsMcMIpN_wemTFqu5Yxoe-TGe2sbJm07Jg8LOUrpawO5gE5Zpp3nezYjHx6GX5gLtgMwee0U4pNxjKlsWBpoF9jbsK4znAbpil5GKYKwGoIYyh1uw5pbFLfxDClKcVtAe9vIYcVPiJHPcSCjw99Tj6-fvXh_E27vFpcnJ8tWy-s4i12RgEDrZBxBWJXKxDScq6tokr2mve9V0YKro0VYL1gaBRFxbw33og5eb7XnXL6vsGydkMoHmOEEdOmOEO17aRWFXyxB6vPUjL2bsphgLx1jLpdjm7n3v3JscJPD6qbzwOu7tBDcBV4dgCgeIh9htGHcscZ2fGumpkTtud-hojb_7x0i-XF2d_n7f6mRoy__t1A_ua0EUa5m8uFu755ey3ev5NuKX4D-keacw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70698465</pqid></control><display><type>article</type><title>Diverse microglial responses after intrahippocampal administration of lipopolysaccharide</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Herber, Donna L. ; Maloney, Jessica L. ; Roth, Lisa M. ; Freeman, Melissa J. ; Morgan, Dave ; Gordon, Marcia N.</creator><creatorcontrib>Herber, Donna L. ; Maloney, Jessica L. ; Roth, Lisa M. ; Freeman, Melissa J. ; Morgan, Dave ; Gordon, Marcia N.</creatorcontrib><description>Inflammation has been argued to play a primary role in the pathogenesis of Alzheimer's disease by contributing to the development of neuropathology and clinical symptoms. However, the mechanisms underlying these effects remain obscure. Lipopolysaccharide (LPS) activates the innate immune response and triggers gliosis when injected into the central nervous system. In the studies described in the present work, we evaluated the time course of microgliosis after a single intrahippocampal injection of LPS. Mice were injected bilaterally with 4 μg of LPS. Post‐injection survival times were 1, 6, and 24 h, as well as 3, 7, 14, and 28 days. Protein and RNA analyses were performed for inflammatory markers. Significant elevations of cluster differentiation marker CD45, glial fibrillary acidic protein (GFAP), scavenger receptor A (SRA), and Fcγ receptor mRNA were seen after 24 h. Immunohistochemistry revealed a complex pattern of protein expression by microglia, as well as changes in cell morphologies. RNA and protein for Fcγ receptor and SRA were transiently elevated, peaked at 3 days, and returned to basal levels after 1 week. In contrast, microglia remained significantly activated through the 28‐day time point, as determined by CD45 and complement receptor 3 levels. These findings indicate a multivariate response to LPS, and evaluation of microglial phenotypes may lead to a better understanding of neuroinflammatory diseases. © 2005 Wiley‐Liss, Inc.</description><identifier>ISSN: 0894-1491</identifier><identifier>EISSN: 1098-1136</identifier><identifier>DOI: 10.1002/glia.20272</identifier><identifier>PMID: 16288481</identifier><identifier>CODEN: GLIAEJ</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Alzheimer's disease ; Animals ; Biological and medical sciences ; Biomarkers ; CD45 ; complement receptor ; Cytokines - metabolism ; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases ; Fundamental and applied biological sciences. Psychology ; Glial Fibrillary Acidic Protein - metabolism ; hippocampus ; Hippocampus - cytology ; Hippocampus - drug effects ; Immunohistochemistry ; inflammation ; Isolated neuron and nerve. Neuroglia ; Leukocyte Common Antigens - metabolism ; Lipopolysaccharides - administration & dosage ; Lipopolysaccharides - pharmacology ; Macrophage Activation - drug effects ; Macrophage-1 Antigen - metabolism ; Medical sciences ; Mice ; microglia ; Microglia - drug effects ; Microinjections ; Neurology ; Receptors, IgG - metabolism ; Reverse Transcriptase Polymerase Chain Reaction ; RNA - analysis ; RNA - biosynthesis ; scavenger receptor ; Scavenger Receptors, Class A - metabolism ; Signal Transduction - drug effects ; Survival ; toll-like receptor 4 ; Toll-Like Receptor 4 - metabolism ; Vertebrates: nervous system and sense organs</subject><ispartof>Glia, 2006-03, Vol.53 (4), p.382-391</ispartof><rights>Copyright © 2005 Wiley‐Liss, Inc.</rights><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3952-e875a1a65e125a33333da34922695054f62ffc574326793a9c31e750e51cc7c73</citedby><cites>FETCH-LOGICAL-c3952-e875a1a65e125a33333da34922695054f62ffc574326793a9c31e750e51cc7c73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fglia.20272$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fglia.20272$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17482833$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16288481$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Herber, Donna L.</creatorcontrib><creatorcontrib>Maloney, Jessica L.</creatorcontrib><creatorcontrib>Roth, Lisa M.</creatorcontrib><creatorcontrib>Freeman, Melissa J.</creatorcontrib><creatorcontrib>Morgan, Dave</creatorcontrib><creatorcontrib>Gordon, Marcia N.</creatorcontrib><title>Diverse microglial responses after intrahippocampal administration of lipopolysaccharide</title><title>Glia</title><addtitle>Glia</addtitle><description>Inflammation has been argued to play a primary role in the pathogenesis of Alzheimer's disease by contributing to the development of neuropathology and clinical symptoms. However, the mechanisms underlying these effects remain obscure. Lipopolysaccharide (LPS) activates the innate immune response and triggers gliosis when injected into the central nervous system. In the studies described in the present work, we evaluated the time course of microgliosis after a single intrahippocampal injection of LPS. Mice were injected bilaterally with 4 μg of LPS. Post‐injection survival times were 1, 6, and 24 h, as well as 3, 7, 14, and 28 days. Protein and RNA analyses were performed for inflammatory markers. Significant elevations of cluster differentiation marker CD45, glial fibrillary acidic protein (GFAP), scavenger receptor A (SRA), and Fcγ receptor mRNA were seen after 24 h. Immunohistochemistry revealed a complex pattern of protein expression by microglia, as well as changes in cell morphologies. RNA and protein for Fcγ receptor and SRA were transiently elevated, peaked at 3 days, and returned to basal levels after 1 week. In contrast, microglia remained significantly activated through the 28‐day time point, as determined by CD45 and complement receptor 3 levels. These findings indicate a multivariate response to LPS, and evaluation of microglial phenotypes may lead to a better understanding of neuroinflammatory diseases. © 2005 Wiley‐Liss, Inc.</description><subject>Alzheimer's disease</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Biomarkers</subject><subject>CD45</subject><subject>complement receptor</subject><subject>Cytokines - metabolism</subject><subject>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Glial Fibrillary Acidic Protein - metabolism</subject><subject>hippocampus</subject><subject>Hippocampus - cytology</subject><subject>Hippocampus - drug effects</subject><subject>Immunohistochemistry</subject><subject>inflammation</subject><subject>Isolated neuron and nerve. Neuroglia</subject><subject>Leukocyte Common Antigens - metabolism</subject><subject>Lipopolysaccharides - administration & dosage</subject><subject>Lipopolysaccharides - pharmacology</subject><subject>Macrophage Activation - drug effects</subject><subject>Macrophage-1 Antigen - metabolism</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>microglia</subject><subject>Microglia - drug effects</subject><subject>Microinjections</subject><subject>Neurology</subject><subject>Receptors, IgG - metabolism</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>RNA - analysis</subject><subject>RNA - biosynthesis</subject><subject>scavenger receptor</subject><subject>Scavenger Receptors, Class A - metabolism</subject><subject>Signal Transduction - drug effects</subject><subject>Survival</subject><subject>toll-like receptor 4</subject><subject>Toll-Like Receptor 4 - metabolism</subject><subject>Vertebrates: nervous system and sense organs</subject><issn>0894-1491</issn><issn>1098-1136</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE9vEzEQxS1ERUPgwgdAe4ED0rb-7_WxKhAqolYIaLlZgzNLDd71YidAvj0OCfTGXEYz-s0bvUfIE0ZPGKX89EsMcMIpN_wemTFqu5Yxoe-TGe2sbJm07Jg8LOUrpawO5gE5Zpp3nezYjHx6GX5gLtgMwee0U4pNxjKlsWBpoF9jbsK4znAbpil5GKYKwGoIYyh1uw5pbFLfxDClKcVtAe9vIYcVPiJHPcSCjw99Tj6-fvXh_E27vFpcnJ8tWy-s4i12RgEDrZBxBWJXKxDScq6tokr2mve9V0YKro0VYL1gaBRFxbw33og5eb7XnXL6vsGydkMoHmOEEdOmOEO17aRWFXyxB6vPUjL2bsphgLx1jLpdjm7n3v3JscJPD6qbzwOu7tBDcBV4dgCgeIh9htGHcscZ2fGumpkTtud-hojb_7x0i-XF2d_n7f6mRoy__t1A_ua0EUa5m8uFu755ey3ev5NuKX4D-keacw</recordid><startdate>200603</startdate><enddate>200603</enddate><creator>Herber, Donna L.</creator><creator>Maloney, Jessica L.</creator><creator>Roth, Lisa M.</creator><creator>Freeman, Melissa J.</creator><creator>Morgan, Dave</creator><creator>Gordon, Marcia N.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley-Liss</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200603</creationdate><title>Diverse microglial responses after intrahippocampal administration of lipopolysaccharide</title><author>Herber, Donna L. ; Maloney, Jessica L. ; Roth, Lisa M. ; Freeman, Melissa J. ; Morgan, Dave ; Gordon, Marcia N.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3952-e875a1a65e125a33333da34922695054f62ffc574326793a9c31e750e51cc7c73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Alzheimer's disease</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Biomarkers</topic><topic>CD45</topic><topic>complement receptor</topic><topic>Cytokines - metabolism</topic><topic>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Glial Fibrillary Acidic Protein - metabolism</topic><topic>hippocampus</topic><topic>Hippocampus - cytology</topic><topic>Hippocampus - drug effects</topic><topic>Immunohistochemistry</topic><topic>inflammation</topic><topic>Isolated neuron and nerve. Neuroglia</topic><topic>Leukocyte Common Antigens - metabolism</topic><topic>Lipopolysaccharides - administration & dosage</topic><topic>Lipopolysaccharides - pharmacology</topic><topic>Macrophage Activation - drug effects</topic><topic>Macrophage-1 Antigen - metabolism</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>microglia</topic><topic>Microglia - drug effects</topic><topic>Microinjections</topic><topic>Neurology</topic><topic>Receptors, IgG - metabolism</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>RNA - analysis</topic><topic>RNA - biosynthesis</topic><topic>scavenger receptor</topic><topic>Scavenger Receptors, Class A - metabolism</topic><topic>Signal Transduction - drug effects</topic><topic>Survival</topic><topic>toll-like receptor 4</topic><topic>Toll-Like Receptor 4 - metabolism</topic><topic>Vertebrates: nervous system and sense organs</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Herber, Donna L.</creatorcontrib><creatorcontrib>Maloney, Jessica L.</creatorcontrib><creatorcontrib>Roth, Lisa M.</creatorcontrib><creatorcontrib>Freeman, Melissa J.</creatorcontrib><creatorcontrib>Morgan, Dave</creatorcontrib><creatorcontrib>Gordon, Marcia N.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Glia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Herber, Donna L.</au><au>Maloney, Jessica L.</au><au>Roth, Lisa M.</au><au>Freeman, Melissa J.</au><au>Morgan, Dave</au><au>Gordon, Marcia N.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diverse microglial responses after intrahippocampal administration of lipopolysaccharide</atitle><jtitle>Glia</jtitle><addtitle>Glia</addtitle><date>2006-03</date><risdate>2006</risdate><volume>53</volume><issue>4</issue><spage>382</spage><epage>391</epage><pages>382-391</pages><issn>0894-1491</issn><eissn>1098-1136</eissn><coden>GLIAEJ</coden><abstract>Inflammation has been argued to play a primary role in the pathogenesis of Alzheimer's disease by contributing to the development of neuropathology and clinical symptoms. However, the mechanisms underlying these effects remain obscure. Lipopolysaccharide (LPS) activates the innate immune response and triggers gliosis when injected into the central nervous system. In the studies described in the present work, we evaluated the time course of microgliosis after a single intrahippocampal injection of LPS. Mice were injected bilaterally with 4 μg of LPS. Post‐injection survival times were 1, 6, and 24 h, as well as 3, 7, 14, and 28 days. Protein and RNA analyses were performed for inflammatory markers. Significant elevations of cluster differentiation marker CD45, glial fibrillary acidic protein (GFAP), scavenger receptor A (SRA), and Fcγ receptor mRNA were seen after 24 h. Immunohistochemistry revealed a complex pattern of protein expression by microglia, as well as changes in cell morphologies. RNA and protein for Fcγ receptor and SRA were transiently elevated, peaked at 3 days, and returned to basal levels after 1 week. In contrast, microglia remained significantly activated through the 28‐day time point, as determined by CD45 and complement receptor 3 levels. These findings indicate a multivariate response to LPS, and evaluation of microglial phenotypes may lead to a better understanding of neuroinflammatory diseases. © 2005 Wiley‐Liss, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>16288481</pmid><doi>10.1002/glia.20272</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0894-1491 |
ispartof | Glia, 2006-03, Vol.53 (4), p.382-391 |
issn | 0894-1491 1098-1136 |
language | eng |
recordid | cdi_proquest_miscellaneous_70698465 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Alzheimer's disease Animals Biological and medical sciences Biomarkers CD45 complement receptor Cytokines - metabolism Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases Fundamental and applied biological sciences. Psychology Glial Fibrillary Acidic Protein - metabolism hippocampus Hippocampus - cytology Hippocampus - drug effects Immunohistochemistry inflammation Isolated neuron and nerve. Neuroglia Leukocyte Common Antigens - metabolism Lipopolysaccharides - administration & dosage Lipopolysaccharides - pharmacology Macrophage Activation - drug effects Macrophage-1 Antigen - metabolism Medical sciences Mice microglia Microglia - drug effects Microinjections Neurology Receptors, IgG - metabolism Reverse Transcriptase Polymerase Chain Reaction RNA - analysis RNA - biosynthesis scavenger receptor Scavenger Receptors, Class A - metabolism Signal Transduction - drug effects Survival toll-like receptor 4 Toll-Like Receptor 4 - metabolism Vertebrates: nervous system and sense organs |
title | Diverse microglial responses after intrahippocampal administration of lipopolysaccharide |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T10%3A43%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diverse%20microglial%20responses%20after%20intrahippocampal%20administration%20of%20lipopolysaccharide&rft.jtitle=Glia&rft.au=Herber,%20Donna%20L.&rft.date=2006-03&rft.volume=53&rft.issue=4&rft.spage=382&rft.epage=391&rft.pages=382-391&rft.issn=0894-1491&rft.eissn=1098-1136&rft.coden=GLIAEJ&rft_id=info:doi/10.1002/glia.20272&rft_dat=%3Cproquest_cross%3E70698465%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70698465&rft_id=info:pmid/16288481&rfr_iscdi=true |